The challenges of psychopharmacogenetics

American Journal of Human Genetics

Volumn 65, Issue 3, 1999, Pages 606-610

  Catalano, Marco ^a  

^a DSNP   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEPRESSION; ENZYME METABOLISM; GENETIC ANALYSIS; PHARMACOGENETICS; PRIORITY JOURNAL; PROMOTER REGION; PSYCHOPHARMACOLOGY; REVIEW;

EID: 0033358670     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302559     Document Type: Article

References (35)

1. Andreassen OA, MacEwan T, Gulbrandsen AK, McCreadie RG, Steen VM (1997) Non-functional CYP2D6 alleles and risk for neuroleptic-induced movement disorders in schizophrenic patients. Psychopharmacology (Berl) 131:174-179
2. Armstrong M, Daly AK, Blennerhassett R, Ferrier N, Idle JR (1997) Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotype. Br J Psychiatry 170:23-26
3. Arranz, MJ, Munro J, Owen MJ, Spurlock G, Sham PC, Zhao J, Kirov G, et al (1998a) Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine. Mol Psychiatry 3:61-66
4. Arranz MJ, Munro J, Sham P, Kirov G, Murray RM, Collier DA, Kerwin RW (1998b) Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response. Schizophr Res 32:93-99
5. Billett EA, Richter MA, King N, Heils A, Lesch KP, Kennedy JL (1997) Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene. Mol Psychiatry 2:403-406
6. Chen CH, Lee YR, Wei FC, Koong FJ, Hwu HG, Hsiao KJ (1997) Lack of allelic association between 102T/C polymorphism of serotonin receptor type 2A gene and schizophrenia in Chinese. Psychiatr Genet 7:35-38
7. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, Nothen MM, et al (1999) Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621-624
8. de Leon J, Barnhill J, Rogers T, Boyle J, Chou WH, Wedlund PJ (1998) Pilot study of the cytochrome P450-2D6 genotype in a psychiatric state hospital. Am J Psychiatry 155:1278-1280
9. Frackiewicz, EJ, Sramek JJ, Herrera JM, Kurtz NM, Cutler NR (1997) Ethnicity and antipsychotic response. Ann Pharmacother 31:1360-1369
10. Franchini L, Serretti A, Gasperini M, Smeraldi E (1998) Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees. J Psychiatr Res 32:255-259
11. Heils A, Teufel A, Petri S, Stöber G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621-2624
12. Hwu HG, Hong CJ, Lee YL, Lee PC, Lee SF (1998) Dopamine D4 receptor gene polymorphisms and neuroleptic response in schizophrenia. Biol Psychiatry 44:483-487
13. Kapitany T, Meszaros K, Lenzinger E, Schindler SD, Barnas C, Fuchs K, Sieghart W, et al (1998) Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia. Schizophr Res 32:101-106
14. Kawanishi C, Hanihara T, Maruyama Y, Matsumura T, Onishi H, Inoue K, Sugiyama N, et al (1997) Neuroleptic malignant syndrome and hydroxylase gene mutations: no association with CYP2D6A or CYP2D6B. Psychiatr Genet 7:127-129
15. Kuoppamaki M, Palvimaki EP, Hietala J, Syvalahti E (1995) Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotics drugs. Neuropsychopharmacology 13:139-150
16. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, et al (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531
17. Malhotra AK, Goldman D, Ozaki N, Breier A, Buchanan R, Pickar D (1996) Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine. Am J Psychiatry 153:1092-1094
18. Masellis M, Basile V, Meltzer HY, Lieberman JA, Sevy S, Macciardi FM, Cola P, et al (1998) Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients. Neuropsychopharmacology 19:123-132
19. Meltzer HY (1994) An overview of the mechanism of action of clozapine. J Clin Psychiatry 55 Suppl B:47-52
20. Mihara K, Otani K, Suzuki A, Yasui N, Nakano H, Meng X, Ohkubo T, et al (1997a) Relationship between the CYP2D6 genotype and the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine. Psychopharmacology (Berl) 133:95-98
21. Mihara K, Otani K, Tybring G, Dahl ML, Bertilsson L, Kaneko S (1997b) The CYP2D6 genotype and plasma concentrations of mianserin enantiomers in relation to therapeutic response to mianserin in depressed Japanese patients. J Clin Psychopharmacol 17:467-471
22. Peroutka SJ (1997) The medical utility of genomics data in neuropsychiatry: mutational genetics versus association genetics. Curr Opin Biotechnol 8:688-691
23. Politi E, Balduzzi C, Bussi R, Bellodi L. Artificial neural networks: a study in clinical psychopharmacology. J Psychiatr Res (in press)
24. Rietschel M, Naber D, Fimmers R, Moller HJ, Propping P, Nothen MM (1997) Efficacy and side-effects of clozapine not associated with variation in the 5-HT2C receptor. Neuroreport 8:1999-2003
25. Rietschel M, Naber D, Oberlander H, Holzbach R, Fimmers R, Eggermann K, Moller HJ, et al (1996) Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene. Neuropsychopharmacology 15:491-496
26. Shih JC, Thompson RF (1999) Monoamine oxidase in neuropsychiatry and behavior. Am J Hum Genet 65:593-598 (in this issue)
27. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M (1998) Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3:508-511
28. Smith MW, Mendoza RP (1996) Ethnicity and pharmacogenetics. Mt Sinai J Med 63:285-290
29. Smoller JW, Tsuang MT (1998) Panic and phobic anxiety: defining phenotypes for genetic studies. Am J Psychiatry 155:1152-1162
30. Sodhi MS, Arranz MJ, Curtis D, Ball DM, Sham P, Roberts GW, Price J, et al (1995) Association between clozapine response and allelic variation in the 5-HT2C receptor gene. Neuroreport 7:169-172
31. van Praag HM (1997) Over the mainstream; diagnostic requirements for biological psychiatric research. Psychiatry Res 72:201-212
32. Varner RV, Ruiz P, Small DR (1998) Black and white patients response to antidepressant treatment for major depression. Psychiatr Q 69:117-125
33. Vogel F (1959) Moderne probleme der humagenetik. Ergeb Inn Med Kinderheilkd 12:52-125
34. Zanardi R, Benedetti F, Di Bella D, Catalano M, Smeraldi E. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J Clin Psychopharmacol (in press)
35. Zenner MT, Nobile M, Henningsen R, Smeraldi E, Civelli O, Hartman DS, Catalano M (1998) Expression and characterization of a dopamine D4R variant associated with delusional disorder. FEBS Lett 422:146-150